rxstat › Classes › Antiinfectives
Antiinfectives: shortage status in Canada
9 of the 11 antiinfectives rxstat tracks are currently in shortage in Canada. When one drug in a class is short, demand often shifts to its alternatives, so related drugs can tighten too; each page below shows which manufacturers are affected and the latest recovery estimates.
Widespread shortageGatifloxacin2 of 3 reported products affected · est. return Sep 4, 2026Widespread shortageGentamicin2 of 2 reported products affectedPartial shortageErythromycin1 of 16 reported products affectedPartial shortageGramicidin Polymyxin B1 of 2 reported products affected · est. return Jun 1, 2026Partial shortageMoxifloxacin6 of 18 reported products affected · est. return Dec 31, 2026Partial shortageOfloxacin1 of 2 reported products affected · est. return Jul 30, 2026Partial shortagePolymyxin B Gramicidin Neomycin1 of 1 reported products affectedPartial shortageSulfacetamide1 of 1 reported products affectedPartial shortageTrimethoprim Polymyxin B1 of 1 reported products affected · est. return Jul 10, 2026DiscontinuedTrifluridine0 of 1 reported products affectedDiscontinuedTrimethoprim Polymyxin B0 of 1 reported products affected
Class groupings follow the WHO ATC classification in Health Canada's reports. Data reflects manufacturer mandatory filings; see methodology.